600873 梅花生物
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(1,155,557)4,009,2604,626,7155,228,9375,654,954
投资活动产生之现金流量净额(526,905)(3,144,181)(2,648,959)(1,509,146)(1,738,222)
筹资活动产生之现金流量净额97,011(1,007,532)(2,738,052)(3,108,097)(3,093,970)
汇率变动对现金及现金等价物的影响(31,457)17,029111,54140,12151,055
现金及现金等价物净增加/(减少)(1,616,908)(125,424)(648,755)651,815873,817
期初现金及现金等价物余额4,006,4364,131,8604,780,6144,128,8003,254,983
期末现金及现金等价物余额2,389,5284,006,4364,131,8604,780,6144,128,800